About Penn Medicine and the Roberts Proton Therapy Center
Penn Medicine’s history goes back to 1751 with the founding of the United States’ first hospital, Pennsylvania Hospital, and the nation’s first medical school at the University of Pennsylvania in 1765. Based in Philadelphia, PA, Penn Medicine is part of the world-renowned University of Pennsylvania and it is known for delivering state-of-the-art care and discovering new treatments
and cures that drive innovation in medicine. Since 2017, it has received 21 FDA approvals and is the epicenter of Cell and Gene Therapy, as well as being a home to the mRNA vaccine technology used in the Pfizer and Moderna COVID-19 vaccines.
The Penn Medicine Roberts Proton Therapy Center is a pioneering institution at the forefront of cancer treatment and research. Located in Philadelphia, Pennsylvania, this state-of-the-art facility has earned international recognition for its exceptional advancements in proton therapy.
The Roberts Proton Therapy Center features cutting-edge technology and a multidisciplinary approach that combines the expertise of leading physicians, scientists, and researchers. Its mission is centered on delivering the most precise and effective cancer treatments while minimizing the impact on healthy tissues and organs.
As home to the world's most advanced proton therapy system, the Roberts Proton Therapy Center provides a comprehensive range of treatment options for various types of cancers. The center's exceptional capabilities extend to treating patients of all ages from pediatric to adult, ensuring optimal care across all age groups.
Collaboration and innovation are at the core of the Roberts Proton Therapy Center's success. Renowned physicians, physicists, and radiation therapists collaborate to develop personalized treatment plans tailored to each patient's needs. This patient-centric approach ensures the highest level of care and the best possible treatment outcomes.
In addition to patient care, the center also emphasizes research and education. It actively engages in groundbreaking clinical trials and research studies to continuously improve proton therapy techniques and expand its applications. Furthermore, the center serves as a hub for training and educating healthcare professionals, contributing to the advancement of proton therapy worldwide.
Through its unwavering commitment to excellence, innovation, and patient well-being, the Penn Medicine Roberts Proton Therapy Center continually redefines the standards of cancer treatment. Serving as a beacon of hope and a catalyst for change, it plays a pivotal role in shaping the future of oncology and presenting new possibilities for patients facing cancer.
About Hamad Medical Corporation
Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East.
For more than four decades, HMC has been dedicated to delivering the safest, most effective, and compassionate care to all its patients.
HMC manages 12 hospitals – nine specialist hospitals and three community hospitals – as well as the National Ambulance Service and home and residential care services.
HMC is leading the development of the region’s first academic health system – combining innovative research, top-class education, and excellent clinical care – and is committed to building a legacy of healthcare expertise in Qatar.
